25.8 C
Delhi
Sunday, August 31, 2025

Elon Musk’s Neuralink gets FDA approval for in-human clinical study

Date:

Share post:

Donate-GC-Razorpay

Los Angeles: Neuralink, Elon Musk’s brain-machine interface company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct its first in-human clinical study.

“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” the company tweeted.

Neuralink said recruitment for its clinical trial “is not open yet.”

The FDA has not commented on the trial. And the extent of the approved trial is not known yet.

Neuralink was founded in 2016 and funded primarily by Musk to develop a new kind of interface technology between the human brain and computing devices.

Installing a chip in the human skull could restore limb function, improve human movement, resolve issues with eyesight and hearing, and help with diseases like Parkinson’s, the company claims.

Related articles

Self-reliance in Defence is not merely an option, but a condition for survival & progress: Rajnath Singh

New Delhi: Defence Minister Rajnath Singh said that in today’s era of terrorism, pandemics and regional conflicts, self-reliance...

Putin advocates reforms in UN, IMF to reflect modern realities

Moscow/Beijing: Russian President Vladmir Putin, ahead of the upcoming SCO summit in the Chinese city of Tianjin, lauded...

India’s GDP surges 7.8 pc in Q1 FY 26, led by services and manufacturing

New Delhi: India’s economy sprinted ahead in the first quarter of FY 2025-26, with real Gross Domestic Product...

India crush Nepal 5-0 to clinch SAFF U17 Women’s Championship 2025 title

New Delhi/Thimphu: India’s dominance in South Asian football continued as the U 17 women’s team thrashed Nepal 5-0...